Mad in America

JUNE 19, 2025

House Bill 25-1063 , approved in April 2025, represents one such effort, revealing the intersection of commercial interests, intellectual property concerns, and the pharmaceutical model’s influence on psychedelic policy.

Psychedelic therapy

Psychiatric Times

JULY 16, 2025

Dzmitry/AdobeStock On Friday July 18, 2025, the US Food and Drug Administration (FDA) advisory committee will discuss the supplemental New Drug Application (sNDA) for brexpiprazole (Rexulti) tablets, submitted by Otsuka Pharmaceutical Company, for the treatment of adults with posttraumatic stress disorder (PTSD), in combination with sertraline.

Sleep and mental health

Mad in America

MARCH 19, 2025

I was the only educational psychology student in these classes, surrounded by people studying curriculum theory, the philosophy of education, educational technology, and the history of education. For me, its impossible to separate this from the role of social media, the internet, and digital technologies.

Poverty and mental health

Behavioral Collective Podcast

OCTOBER 18, 2023

They previously conducted graduate studies at UNT, where they worked with Manish on collaborative projects related to surface electromyographic technology. Initially, the goal wasn’t to change physical therapy but rather to explore the potential of sEMG technology. Sacheen is an orthopedic surgeon practicing in Richardson, Texas.

Technology

Psychiatric Times

JULY 2, 2025

Download Issue PDF Articles in this issue History, Physiology, and Pharmacology of Incretins Newsletter Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients. Subscribe Now!

Bipolar disorder

Mad in America

JULY 24, 2025

We are using this technology already at HHS to manage health care data, perfectly securely, and to increase the speed of drug approvals,” he told the House Energy and Commerce Committee in June. “The AI revolution has arrived,” Health and Human Services Secretary Robert F. Kennedy Jr. The enthusiasm — among some, at least — was palpable.

Pharmaceuticals

Mad in America

JANUARY 24, 2024

Bolstered by the aggressive marketing of pharmaceuticals as precise tools targeting specific genetic markers, pharmacogenomics risks fuelling a cycle of dependency just as debilitating as the mental health conditions they aim to treat.

Genetics and mental health

Mad in America

JANUARY 18, 2024

In recent years this has hardened up, as information technology and population data have converged to allow larger and more convincing studies. The result is a set of findings which have yet to find a satisfactory explanation.

Self-awareness

Mad in America

FEBRUARY 20, 2024

He rattles on about statistics, techniques, “behavioral interventions” and other technologies that show “statistically significant” effects in modifying student and adolescent behavior. Green’s anecdotes by reference to a number of scientific studies—the absolute pinnacle of knowledge.

Education

Mad in America

DECEMBER 4, 2023

Blaming greedy lawyers for our healthcare cost problem comes under the same category as blaming modern medical advances, the expensive new technology and medicines to identify—and at times—cure diseases, and other common “red herrings” in the healthcare industry.

Healthcare

Mad in America

OCTOBER 21, 2023

In these interviews, I have talked about the components of the psychiatric-pharmaceutical-industrial complex, along with how psychiatry meets the political needs of the ruling class and dysfunctional families. Mainstream media is another major player in the psychiatric-pharmaceutical-industrial complex. Evolutionary geneticist R.C.

Technology

Association for Psychological Science (APS)

MAY 1, 2025

So as I say, this is being picked up by pharmaceutical companies, by computer science labs, by all the big tech companies, and they’re all based on our data. [00:08:23.600] Like you said, with the new technologies, language could be one of the predictors of these episodes. That’s quite exciting, too. [00:12:03.010]

Retail

Mad in America

OCTOBER 22, 2024

However, the problem of smartphones is in some ways particularly emblematic of the perverse dynamics of our technological society. Almost every advance in technology makes corresponding demands on the human person. The servant becomes the master. In short, the same effects appear regardless of the character of the intervention.

Trauma and the brain

Mad in America

SEPTEMBER 20, 2024

The Australian Government doesn’t recognize that withdrawal from psychiatric drugs is anything to worry about for the overwhelming majority of patients, so doctors here know only what the pharmaceutical companies and the expert advisory bodies influenced by those companies want them to know, which is effectively nothing useful to the patient.

Aging and mental health

Mad in America

APRIL 24, 2024

The middle class has come to understand genetics, biotechnology, and pharmaceuticals and is better educated in science and technology. Regarding treatments, you have yourself written that psycho-pharmaceuticals have been found to be a lot less effective and have severe adverse effects.

Global mental health

Mad in America

MARCH 15, 2024

To give this story some more context, at the start of 1995 I had been working as a dental technician in a busy crown and bridge dental laboratory in Wellington city, after completing a diploma in dental technology at the close of 1994. I had been a student at the Central Institute of Technology between 1992 and 1994.

Aging and mental health

Real Psychiatry

APRIL 11, 2025

A recent commentary in the NEJM pointed out the potential problems of the new relationship between pharmaceutical companies and telehealth firms (1). Expectedly he is an unabashed promoter of computer technology and the latest version artificial intelligence or AI. It is as easy to imagine as the following thought experiment.

Pharmaceuticals

Mad in America

AUGUST 3, 2024

However, rather than people becoming enraged and politically engaged to change carcinogenic environments, an extremely powerful medical-pharmaceutical industrial complex has controlled the societal narrative to focus—not on eliminating environmental-societal causes of cancer—but on expensive cancer treatments. between 1990 and 2019.”

Genetics and mental health

Mad in America

NOVEMBER 27, 2024

The mental health industry, including therapists, pharmaceutical companies, and even heads of departments and trauma experts, have a vested interest in diagnosing as many individuals as possible. Life expectancy has increased globally due to advancements in medical technology, better hygiene, and improved access to healthcare.

Resilience and coping